Skip to main content
. Author manuscript; available in PMC: 2022 May 12.
Published in final edited form as: Pharm Res. 2021 May 12;38(5):803–817. doi: 10.1007/s11095-021-03046-4

Fig. 13: Oxidative stress reduction by NL-1 in ischemic reperfusion injury.

Fig. 13:

NL-1 reduced the levels of the oxidative stress marker 4-hydroxynonenal in tMCAO mice when treated with 10 mg/kg NL-1.